Essex Private Wealth Management’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Essex Private Wealth Management’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10,000	Closed	-$4.32K	–	27
2023 Q1	$4.32K	Hold	10,000	–	–	0.02%	26
2022 Q4	$11.8K	Hold	10,000	–	–	0.04%	30
2022 Q3	$23K	Buy	+10,000	New	+$26.2K	0.09%	29

Other funds holding GRNA

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

CGC

Continental Grain Company New York $448M AUM 6.81% 1-Year Est. Return

TCM

Tao Capital Management San Francisco, California $119M AUM 87.46% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

BOTOTLSJU

Board of Trustees of The Leland Stanford Junior University Redwood City, California $533M AUM 65.58% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return

Essex Private Wealth Management's GRNA Position: Q2 2023 in Review

Essex Private Wealth Management sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q2 2023, closing a stake of 10,000 shares — an estimated $4.32K sold.

Essex Private Wealth Management first reported a position in GRNA in Q3 2022 and held it in 3 quarters. The position peaked at $23K in Q3 2022. 48 funds tracked by Wall St. Rank hold GRNA as of Q2 2023.

Essex Private Wealth Management reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q2 2023 after selling out during the quarter.
Essex Private Wealth Management sold 10,000 GreenLight Biosciences Holdings, PBC Common Stock shares in Q2 2023, an estimated $4.32K.
Essex Private Wealth Management first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q3 2022 and held it in 3 quarters.
Essex Private Wealth Management's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $23K in Q3 2022.
48 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q2 2023.

Based on Essex Private Wealth Management's 13F filing for Q2 2023, filed 31 Jul 2023.